InMed Announces Publication of Peer-Reviewed Study Highlighting Potential Role of Rare Cannabinoids THCV, CBC and others… Jun 14, 2022
InMed Pharmaceuticals: Commercializing The Development Of Rare Cannabinoids For The Wellness Market May 18, 2022
InMed Expands Patent Portfolio with Novel Cannabinoid Analogs and Advances Collaboration Agreement with Leading… Apr 28, 2022
InMed Launches Cannabicitran (CBT), Expanding its Rare Cannabinoid Portfolio for the Health and Wellness Sector Jan 19, 2022
InMed Pharmaceuticals Positioned For Growth As Cannabinoid Supply Sales Poised For Imminent “Take Off” Sep 22, 2021
